Category Clinical trials

FAST-EU, an initiative that enables an accelerated assessment of multinational clinical trials in the European Union

This post aims to provide basic information on the FAST-EU initiative. The information is by no means exhaustive. What is the FAST-Initiative? FAST-EU (Facilitating and Accelerating Strategic Clinical Trials) is a pilot initiative by the Heads of Medicines Agencies (HMA),…

Read MoreFAST-EU, an initiative that enables an accelerated assessment of multinational clinical trials in the European Union

National Competent Authorities to launch a fast-track approach for the authorisation of multinational clinical trials in the EU/EEA

On 27 November 2025, a large number of National Competent Authorities (NCAs) and Ethics Committees committed to test a coordinated fast-track approach for evaluating multinational clinical trials. About the FAST-EU (Facilitating and Accelerating Strategic Trials) initiative When is the FAST-EU…

Read MoreNational Competent Authorities to launch a fast-track approach for the authorisation of multinational clinical trials in the EU/EEA

COMBINE programme launches a pilot coordinated assessment for clinical trials and performance studies

Last updated: 27 June 2025 To view updates, click on the ‘+’ sign below. What is COMBINE? COMBINE is one of the initiatives highlighted in the Draghi report to support EU competitiveness in clinical research. When did the COMBINE Project 1 –…

Read MoreCOMBINE programme launches a pilot coordinated assessment for clinical trials and performance studies

AEMPS launches an accelerated evaluation procedure for clinical trials

AEMPS has launched an accelerated evaluation procedure or fast-track with the aim of making Spain a more attractive environment for research into innovative medicines. In general terms, Regulation (EU) No. 536/2014 on clinical trials of medicinal products for human use establishes the maximum deadlines for…

Read MoreAEMPS launches an accelerated evaluation procedure for clinical trials